Registering people getting heated chemotherapy into the abdomen
Part of Cancer, Digestive system clinical trials.
This trial is a registry study that follows people with certain abdominal (peritoneal) cancers who are planned for surgery plus heated chemotherapy placed inside the abdomen. It mainly helps doctors learn about outcomes and care patterns for these treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer spread to the lining of the abdomen (peritoneal carcinomatosis) from colorectal cancer
- OR you have pseudomyxoma peritonei (DPAM or PMCA)
- OR you have peritoneal mesothelioma
- Your doctors plan surgery to remove visible tumor (cytoreductive surgery) and heated chemotherapy inside the abdomen (HIPEC)
- You are being treated for a cancer that affects the surface of the abdomen (peritoneal surface malignancy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests a treatment that delivers heated chemotherapy directly into the abdomen (HIPEC) for certain cancers that have spread only within the abdominal lining. It aims to see how safely and effectively this approach works, especially when doctors can remove as much tumor as possible.
This trial tests if giving heated chemotherapy as a mist (aerosol) is better than as a liquid for cancer that has spread to the lining of the abdomen. It is for people who have already had at least three months of standard chemo but still have disease and cannot have surgery right now.
This study tries to better predict how well patients do after heated chemotherapy placed in the abdomen during surgery for stomach or colon cancer that has spread to the lining of the abdomen. It may help doctors choose the best treatment plan and timing for future patients.
This trial tests whether more chemotherapy after surgery can help people with a specific type of abdominal cancer (malignant peritoneal mesothelioma). It is for those who have had all visible tumor removed and have not had chemotherapy before.
This trial uses a test on your tumor tissue to find which chemotherapy drugs work best for you, after standard surgery and heated chemotherapy. It aims to make your treatment more effective by choosing drugs that match your cancer.
This study looks at how cancers that spread along the belly lining (“peritoneal surface malignancies”) behave and how different treatment strategies may work. It may help improve how doctors select and test treatments for people who are candidates for CRS-HIPEC, a specific cancer surgery approach.
Hear when a new Peritoneal Carcinomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.